Schonfeld Strategic Advisors »

Cerevel Therapeutics Hldng I shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $446k 11k 42.40
2023-06-30 $2.1M 66k 31.79
2022-12-31 $486k 15k 31.54
2021-12-31 $277k 8.5k 32.41
2021-03-31 $178k 13k 13.69

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr U.s. Real Es Etf (IYR)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Verizon Communications (VZ)
Spdr Ser Tr S&p Biotech (XBI)
Micron Technology (MU)
Johnson Ctls Intl SHS (JCI)

View all positions for Schonfeld Strategic Advisors

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I